{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:56:37Z","timestamp":1793138197400,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T00:00:00Z","timestamp":1652745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T00:00:00Z","timestamp":1652745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s10620-022-07525-5","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T12:15:35Z","timestamp":1652789735000},"page":"87-97","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Patient Priorities in Autoimmune Hepatitis: The Need for Better Treatments, More Education and Challenging Stigma"],"prefix":"10.1007","volume":"68","author":[{"given":"Charlotte","family":"Lloyd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Leighton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin Lee","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Goulding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Brownlee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penney","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Culver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Halliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doug","family":"Thorburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Heneghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E. J.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Exley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6733-5225","authenticated-orcid":false,"given":"Jessica K.","family":"Dyson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,17]]},"reference":[{"key":"7525_CR1","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/S0140-6736(12)62163-1","volume":"382","author":"MA Heneghan","year":"2013","unstructured":"Heneghan MA, Yeoman AD, Verma S, Smith AD, Longhi MS. Autoimmune hepatitis. The Lancet. 2013;382:1433\u20131444.","journal-title":"The Lancet."},{"key":"7525_CR2","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMra050408","volume":"354","author":"EL Krawitt","year":"2006","unstructured":"Krawitt EL. Autoimmune hepatitis. New England Journal of Medicine. 2006;354:54\u201366.","journal-title":"New England Journal of Medicine."},{"key":"7525_CR3","doi-asserted-by":"crossref","unstructured":"Ngu JH, Bechly K, Chapman BA et al. 1681 Population-based epidemiology study of autoimmune hepatitis: a disease of older women?. Journal of Gastroenterology & Hepatology, 25: 1681\u20131686","DOI":"10.1111\/j.1440-1746.2010.06384.x"},{"key":"7525_CR4","doi-asserted-by":"crossref","unstructured":"Czaja AJ. Global disparities and their implications in the occurrence and outcome of autoimmune hepatitis. [Review] Digestive Diseases & Sciences. 2277, 62: 2277\u20132292.","DOI":"10.1007\/s10620-017-4675-y"},{"key":"7525_CR5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/00365529850166284","volume":"33","author":"KM Boberg","year":"1998","unstructured":"Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scandinavian Journal of Gastroenterology. 1998;33:99\u2013103.","journal-title":"Scandinavian Journal of Gastroenterology."},{"key":"7525_CR6","doi-asserted-by":"crossref","unstructured":"Gleeson D, Heneghan MA, British Society of G. British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis Gut. 1611, 60: 1611\u20131629.","DOI":"10.1136\/gut.2010.235259"},{"key":"7525_CR7","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","volume":"63","author":"AW Lohse","year":"2015","unstructured":"Lohse AW, Chazouilleres O, Dalekos G et al. EASL clinical practice guidelines: Autoimmune hepatitis. Journal of Hepatology. 2015;63:971\u20131004.","journal-title":"Journal of Hepatology."},{"key":"7525_CR8","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1365-2036.2009.04061.x","volume":"30","author":"A Afendy","year":"2009","unstructured":"Afendy A, Kallman JB, Stepanova M et al. Predictors of health-related quality of life in patients with chronic liver disease. Alimentary Pharmacology and Therapeutics. 2009;30:469\u2013476.","journal-title":"Alimentary Pharmacology and Therapeutics."},{"key":"7525_CR9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/liv.13960","volume":"39","author":"MK Janik","year":"2019","unstructured":"Janik MK, Wunsch E, Raszeja-Wyszomirska J et al. Autoimmune hepatitis exerts a profound, negative effect on health-related quality of life: A prospective, single-centre study. Liver International. 2019;39:215\u2013221.","journal-title":"Liver International."},{"key":"7525_CR10","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.jhep.2013.10.035","volume":"60","author":"C Schramm","year":"2014","unstructured":"Schramm C, Wahl I, Weiler-Normann C et al. Health-related quality of life, depression, and anxiety in patients with autoimmune hepatitis. Journal of Hepatology. 2014;60:618\u2013624.","journal-title":"Journal of Hepatology."},{"key":"7525_CR11","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1002\/hep.30031","volume":"68","author":"LL Wong","year":"2018","unstructured":"Wong LL, Fisher HF, Stocken DD et al. The Impact of Autoimmune Hepatitis and Its Treatment on Health Utility. Hepatology. 2018;68:1487\u20131497.","journal-title":"Hepatology."},{"key":"7525_CR12","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/apt.15111","volume":"49","author":"JK Dyson","year":"2019","unstructured":"Dyson JK, De Martin E, Dalekos GN et al. Review article: unanswered clinical and research questions in autoimmune hepatitis-conclusions of the International Autoimmune Hepatitis Group Research Workshop. Alimentary Pharmacology and Therapeutics. 2019;49:528\u2013536.","journal-title":"Alimentary Pharmacology and Therapeutics."},{"key":"7525_CR13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/oxfordjournals.qjmed.a067264","volume":"40","author":"GC Cook","year":"1971","unstructured":"Cook GC, Mulligan R, Sherlock S. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Quarterly Journal of Medicine. 1971;40:159\u2013185.","journal-title":"Quarterly Journal of Medicine."},{"key":"7525_CR14","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1136\/gut.16.11.876","volume":"16","author":"WH Summerskill","year":"1975","unstructured":"Summerskill WH, Korman MG, Ammon HV, Baggenstoss AH. Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared. Gut. 1975;16:876\u2013883.","journal-title":"Gut."},{"key":"7525_CR15","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S0016-5085(19)33223-8","volume":"63","author":"RD Soloway","year":"1972","unstructured":"Soloway RD, Summerskill WH, Baggenstoss AH et al. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology. 1972;63:820\u2013833.","journal-title":"Gastroenterology."},{"key":"7525_CR16","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0140-6736(73)92125-9","volume":"1","author":"IM Murray-Lyon","year":"1973","unstructured":"Murray-Lyon IM, Stern RB, Williams R. Controlled trial of prednisone and azathioprine in active chronic hepatitis. Lancet. 1973;1:735\u2013737.","journal-title":"Lancet."},{"key":"7525_CR17","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1053\/j.gastro.2010.06.046","volume":"139","author":"MP Manns","year":"2010","unstructured":"Manns MP, Woynarowski M, Kreisel W et al. Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis. Gastroenterology. 2010;139:1198\u20131206.","journal-title":"Gastroenterology."},{"key":"7525_CR18","doi-asserted-by":"publisher","first-page":"S408","DOI":"10.1016\/S1590-8658(11)60638-5","volume":"43","author":"S Nastasio","year":"2011","unstructured":"Nastasio S, Sciveres M, De Tata R, Riva S, Palla G, Maggiore G. Cyclosporin treatment for autoimmune liver diseases is safe and efficacious in the long term. Digestive and Liver Disease. 2011;43:S408.","journal-title":"Digestive and Liver Disease."},{"key":"7525_CR19","first-page":"771","volume":"90","author":"DH Van Thiel","year":"1995","unstructured":"Van Thiel DH, Wright H, Carroll P et al. Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial. American Journal of Gastroenterology. 1995;90:771\u2013776.","journal-title":"American Journal of Gastroenterology."},{"key":"7525_CR20","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.jhep.2010.12.032","volume":"55","author":"K Zachou","year":"2011","unstructured":"Zachou K, Gatselis N, Papadamou G, Rigopoulou EI, Dalekos GN. Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naive patients. Journal of Hepatology. 2011;55:636\u2013646.","journal-title":"Journal of Hepatology."},{"key":"7525_CR21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1136\/bmj.311.6997.109","volume":"311","author":"N Mays","year":"1995","unstructured":"Mays N, Pope C. Qualitative research: rigour and qualitative research. Bmj. 1995;311:109\u2013112.","journal-title":"Bmj."},{"key":"7525_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qualitative research in psychology. 2006;3:77\u2013101.","journal-title":"Qualitative research in psychology."},{"key":"7525_CR23","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/apt.14968","volume":"48","author":"JK Dyson","year":"2018","unstructured":"Dyson JK, Wong LL, Bigirumurame T et al. Inequity of care provision and outcome disparity in autoimmune hepatitis in the United Kingdom. Alimentary Pharmacology & Therapeutics. 2018;48:951\u2013960.","journal-title":"Alimentary Pharmacology & Therapeutics."},{"key":"7525_CR24","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1111\/apt.13794","volume":"44","author":"JK Dyson","year":"2016","unstructured":"Dyson JK, Wilkinson N, Jopson L et al. The inter-relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitis. Aliment Pharmacol Ther. 2016;44:1039\u20131050.","journal-title":"Aliment Pharmacol Ther."},{"key":"7525_CR25","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2190\/IL.18.3.e","volume":"18","author":"ED Sogolow","year":"2010","unstructured":"Sogolow ED, Lasker JN, Sharim RR, Weinrieb RM, Sass DA. Stigma and liver disease Illness. Crisis & Loss. 2010;18:229\u2013255.","journal-title":"Crisis & Loss."},{"key":"7525_CR26","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1053\/gast.2002.32993","volume":"122","author":"J Goldblatt","year":"2002","unstructured":"Goldblatt J, Taylor PJ, Lipman T et al. The true impact of fatigue in primary biliary cirrhosis: a population study. Gastroenterology. 2002;122:1235\u20131241.","journal-title":"Gastroenterology."},{"key":"7525_CR27","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1080\/08870446.2011.565876","volume":"26","author":"L Montali","year":"2011","unstructured":"Montali L, Frigerio A, Riva P, Invernizzi P. \u2018It\u2019s as if PBC didn\u2019t exist\u2019: The illness experience of women affected by primary biliary cirrhosis. Psychology & Health. 2011;26:1429\u20131445.","journal-title":"Psychology & Health."},{"key":"7525_CR28","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1177\/160940691201100409","volume":"11","author":"ES Block","year":"2012","unstructured":"Block ES, Erskine L. Interviewing by telephone: Specific considerations, opportunities, and challenges. International Journal of Qualitative Methods. 2012;11:428\u2013445.","journal-title":"International Journal of Qualitative Methods."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07525-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-022-07525-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07525-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T23:43:07Z","timestamp":1744155787000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-022-07525-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,17]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["7525"],"URL":"https:\/\/doi.org\/10.1007\/s10620-022-07525-5","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,17]]},"assertion":[{"value":"20 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no relevant conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The patient survey was conducted as a service evaluation project with approvals from Newcastle University and Newcastle upon Tyne Hospitals NHS Foundation Trust. All participation was voluntary and no patient identifiable information was collected. As such, Caldicott Approval was obtained but no formal consent or ethical approval were required. For the semi-structured interviews, ethical approval was obtained from the Wales REC 7 proportionate review sub-committee, along with approval from the Health Research Authority (HRA) and Health and Care Research Wales (HCRW) (REC reference 20\/WA\/0041). Informed consent was obtained from all participants. All data collected were audio-recorded, handled and stored securely in accordance with General Data Protection Regulations (GDPR). All participants were given pseudonyms.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}